글로벌 식물성 및 식물 유래 의약품 시장 2023-2027 : 식물약, 식물성 의약품

■ 영문 제목 : Global Botanical and Plant-Derived Drugs Market 2023-2027

Technavio가 발행한 조사보고서이며, 코드는 IRTNTR45751-23 입니다.■ 상품코드 : IRTNTR45751-23
■ 조사/발행회사 : Technavio
■ 발행일 : 2023년 7월
■ 페이지수 : 약120
■ 작성언어 : 영문
■ 보고서 형태 : PDF
■ 납품 방식 : E메일 (주문후 24시간내)
■ 조사대상 지역 : 글로벌
■ 산업 분야 : 의약품
■ 판매가격 / 옵션 (부가세 10% 별도)
Single User (1인 열람용)USD2,500 ⇒환산₩3,375,000견적의뢰/주문/질문
Enterprise License (기업 열람용)USD4,000 ⇒환산₩5,400,000견적의뢰/주문/질문
가격옵션 설명
- 납기는 즉일~2일소요됩니다. 3일이상 소요되는 경우는 별도표기 또는 연락드립니다.
- 지불방법은 계좌이체/무통장입금 또는 카드결제입니다.
글로벌 식물성 및 식물 유래 의약품 시장 2023-2027
식물성 및 식물 유래 의약품 시장은 2022년부터 2027년까지 22억 6,610만 달러 규모로 성장할 것으로 예상되며, 예측 기간 동안 9.23%의 CAGR을 기록할 것으로 예상됩니다. 이 보고서는 식물성 및 식물 유래 의약품 시장에 대한 전반적인 분석, 시장 규모와 예측, 동향, 성장 촉진요인, 과제, 약 25개 벤더를 대상으로 한 벤더 분석 등의 정보를 담고 있습니다.
현재 시장 시나리오, 최신 동향 및 촉진 요인, 전체 시장 환경에 대한 최신 분석을 제공합니다. 이 시장은 식물성 의약품 사용을 위한 정부 이니셔티브의 증가, 기존 의약품과 관련된 제약, 만성 질환의 효과적인 치료에 대한 수요 증가에 의해 주도되고 있습니다.

Technavio사의 식물성 및 식물 유래 의약품 시장은 다음과 같이 분류하고 있습니다.

제품별
- 식물약
- 식물성 의약품

용도별
- 감염성 질환
- 중추신경계
- 순환기계 질환
- 호흡기 질환

지역별
- 아시아
- 유럽
- 북미
- 기타 지역(ROW)

이 보고서는 향후 몇 년간 식물성 및 식물 유래 의약품 시장의 성장을 촉진하는 주요 요인 중 하나로 미국의 규제 환경 변화를 꼽고 있습니다. 또한, 새로운 적응증에 대한 의약품 개발에 대한 관심 증가와 신규 진입 기업의 출현은 시장의 큰 수요로 이어질 것으로 보입니다.

본 보고서는 식물성 및 식물 유래 의약품 시장을 조사하고 분석한 결과를 담고 있습니다.
- 식물성 및 식물 유래 의약품 시장 규모
- 식물성 및 식물 유래 의약품 시장 예측
- 식물성 및 식물 유래 의약품 시장 산업 분석

본 보고서는 식물성 및 식물 유래 의약품 시장의 주요 벤더인 Bausch Health Co. Inc., Bayer AG, Devonian Health Group Inc., Dr. Willmar Schwabe GmbH and Co. KG, F. Hoffmann La Roche Ltd., Hetero Labs Ltd., Jaguar Health Inc., Jazz Pharmaceuticals Plc, Johnson and Johnson Services Inc., Medigene AG, Merck KGaA, Mitsubishi Chemical Group Corp., Novartis AG, Pierre Fabre SA, Protalix Biotherapeutics Inc., Sanofi, 및 Sun Pharmaceutical Industries Ltd. 등의 기업을 분석하고 있습니다. 또한, 식물성 및 식물 유래 의약품 시장 분석 보고서에는 시장 성장에 영향을 미치는 향후 동향과 과제에 대한 정보도 포함되어 있습니다. 이는 기업이 전략을 수립하고 다가오는 모든 성장 기회를 활용하는 데 도움이 될 것입니다.

이 연구는 업계 주요 참여자들의 의견을 포함하여 1차 및 2차 정보를 객관적으로 결합하여 수행되었습니다. 이 보고서는 주요 벤더에 대한 분석과 함께 포괄적인 시장 및 벤더 현황을 제공합니다.

이 보고서는 이익, 가격, 경쟁, 프로모션 등 주요 매개변수를 분석하여 여러 출처의 데이터를 조사, 통합, 요약하는 방식으로 시장의 상세한 모습을 제시합니다. 또한, 주요 산업 영향력자를 식별하여 시장의 다양한 측면을 제시합니다. 제시된 데이터는 포괄적이고 신뢰할 수 있는 1차 및 2차에 걸친 광범위한 조사 결과입니다. 시장 조사 보고서는 정확한 시장 성장을 예측하기 위해 완전한 경쟁 환경과 정성적 및 정량적 조사를 통한 면밀한 공급업체 선정 방법 및 분석을 제공합니다.
■ 보고서 개요

1. 개요
2. 세계의 식물성 및 식물 유래 의약품 시장 현황
3. 세계의 식물성 및 식물 유래 의약품 시장 규모
4. 과거 시장 규모
5. 파이브 포스 분석
6. 제품별 시장 분석
7. 용도별 시장 분석
8. 고객 현황
9. 지역별 분석
10. 추진 요인/과제/동향
11. 기업 현황
12. 기업 분석
13. 부록

■ 보고서 목차

1 Executive Summary
o 1.1 Market overview
o Exhibit 01: Executive Summary – Chart on Market Overview
o Exhibit 02: Executive Summary – Data Table on Market Overview
o Exhibit 03: Executive Summary – Chart on Global Market Characteristics
o Exhibit 04: Executive Summary – Chart on Market By Geographical Landscape
o Exhibit 05: Executive Summary – Chart on Market Segmentation by Product
o Exhibit 06: Executive Summary – Chart on Market Segmentation by Application
o Exhibit 07: Executive Summary – Chart on Incremental Growth
o Exhibit 08: Executive Summary – Data Table on Incremental Growth
o Exhibit 09: Executive Summary – Chart on Vendor Market Positioning
2 Market Landscape
o 2.1 Market ecosystem
o Exhibit 10: Parent market
o Exhibit 11: Market Characteristics
3 Market Sizing
o 3.1 Market definition
o Exhibit 12: Offerings of vendors included in the market definition
o 3.2 Market segment analysis
o Exhibit 13: Market segments
o 3.3 Market size 2022
o 3.4 Market outlook: Forecast for 2022-2027
o Exhibit 14: Chart on Global – Market size and forecast 2022-2027 ($ billion)
o Exhibit 15: Data Table on Global – Market size and forecast 2022-2027 ($ billion)
o Exhibit 16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
o Exhibit 17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
4 Historic Market Size
o 4.1 Global botanical and plant-derived drugs market 2017 – 2021
o Exhibit 18: Historic Market Size – Data Table on global botanical and plant-derived drugs market 2017 – 2021 ($ billion)
o 4.2 Product Segment Analysis 2017 – 2021
o Exhibit 19: Historic Market Size – Product Segment 2017 – 2021 ($ billion)
o 4.3 Application Segment Analysis 2017 – 2021
o Exhibit 20: Historic Market Size – Application Segment 2017 – 2021 ($ billion)
o 4.4 Geography Segment Analysis 2017 – 2021
o Exhibit 21: Historic Market Size – Geography Segment 2017 – 2021 ($ billion)
o 4.5 Country Segment Analysis 2017 – 2021
o Exhibit 22: Historic Market Size – Country Segment 2017 – 2021 ($ billion)
5 Five Forces Analysis
o 5.1 Five forces summary
o Exhibit 23: Five forces analysis – Comparison between 2022 and 2027
o 5.2 Bargaining power of buyers
o Exhibit 24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
o 5.3 Bargaining power of suppliers
o Exhibit 25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
o 5.4 Threat of new entrants
o Exhibit 26: Threat of new entrants – Impact of key factors in 2022 and 2027
o 5.5 Threat of substitutes
o Exhibit 27: Threat of substitutes – Impact of key factors in 2022 and 2027
o 5.6 Threat of rivalry
o Exhibit 28: Threat of rivalry – Impact of key factors in 2022 and 2027
o 5.7 Market condition
o Exhibit 29: Chart on Market condition – Five forces 2022 and 2027
6 Market Segmentation by Product
o 6.1 Market segments
o Exhibit 30: Chart on Product – Market share 2022-2027 (%)
o Exhibit 31: Data Table on Product – Market share 2022-2027 (%)
o 6.2 Comparison by Product
o Exhibit 32: Chart on Comparison by Product
o Exhibit 33: Data Table on Comparison by Product
o 6.3 Plant-derived drugs – Market size and forecast 2022-2027
o Exhibit 34: Chart on Plant-derived drugs – Market size and forecast 2022-2027 ($ billion)
o Exhibit 35: Data Table on Plant-derived drugs – Market size and forecast 2022-2027 ($ billion)
o Exhibit 36: Chart on Plant-derived drugs – Year-over-year growth 2022-2027 (%)
o Exhibit 37: Data Table on Plant-derived drugs – Year-over-year growth 2022-2027 (%)
o 6.4 Botanical drugs – Market size and forecast 2022-2027
o Exhibit 38: Chart on Botanical drugs – Market size and forecast 2022-2027 ($ billion)
o Exhibit 39: Data Table on Botanical drugs – Market size and forecast 2022-2027 ($ billion)
o Exhibit 40: Chart on Botanical drugs – Year-over-year growth 2022-2027 (%)
o Exhibit 41: Data Table on Botanical drugs – Year-over-year growth 2022-2027 (%)
o 6.5 Market opportunity by Product
o Exhibit 42: Market opportunity by Product ($ billion)
o Exhibit 43: Data Table on Market opportunity by Product ($ billion)
7 Market Segmentation by Application
o 7.1 Market segments
o Exhibit 44: Chart on Application – Market share 2022-2027 (%)
o Exhibit 45: Data Table on Application – Market share 2022-2027 (%)
o 7.2 Comparison by Application
o Exhibit 46: Chart on Comparison by Application
o Exhibit 47: Data Table on Comparison by Application
o 7.3 Infectious diseases – Market size and forecast 2022-2027
o Exhibit 48: Chart on Infectious diseases – Market size and forecast 2022-2027 ($ billion)
o Exhibit 49: Data Table on Infectious diseases – Market size and forecast 2022-2027 ($ billion)
o Exhibit 50: Chart on Infectious diseases – Year-over-year growth 2022-2027 (%)
o Exhibit 51: Data Table on Infectious diseases – Year-over-year growth 2022-2027 (%)
o 7.4 Central nervous system – Market size and forecast 2022-2027
o Exhibit 52: Chart on Central nervous system – Market size and forecast 2022-2027 ($ billion)
o Exhibit 53: Data Table on Central nervous system – Market size and forecast 2022-2027 ($ billion)
o Exhibit 54: Chart on Central nervous system – Year-over-year growth 2022-2027 (%)
o Exhibit 55: Data Table on Central nervous system – Year-over-year growth 2022-2027 (%)
o 7.5 Cardiovascular diseases – Market size and forecast 2022-2027
o Exhibit 56: Chart on Cardiovascular diseases – Market size and forecast 2022-2027 ($ billion)
o Exhibit 57: Data Table on Cardiovascular diseases – Market size and forecast 2022-2027 ($ billion)
o Exhibit 58: Chart on Cardiovascular diseases – Year-over-year growth 2022-2027 (%)
o Exhibit 59: Data Table on Cardiovascular diseases – Year-over-year growth 2022-2027 (%)
o 7.6 Respiratory diseases – Market size and forecast 2022-2027
o Exhibit 60: Chart on Respiratory diseases – Market size and forecast 2022-2027 ($ billion)
o Exhibit 61: Data Table on Respiratory diseases – Market size and forecast 2022-2027 ($ billion)
o Exhibit 62: Chart on Respiratory diseases – Year-over-year growth 2022-2027 (%)
o Exhibit 63: Data Table on Respiratory diseases – Year-over-year growth 2022-2027 (%)
o 7.7 Market opportunity by Application
o Exhibit 64: Market opportunity by Application ($ billion)
o Exhibit 65: Data Table on Market opportunity by Application ($ billion)
8 Customer Landscape
o 8.1 Customer landscape overview
o Exhibit 66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
9 Geographic Landscape
o 9.1 Geographic segmentation
o Exhibit 67: Chart on Market share By Geographical Landscape 2022-2027 (%)
o Exhibit 68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
o 9.2 Geographic comparison
o Exhibit 69: Chart on Geographic comparison
o Exhibit 70: Data Table on Geographic comparison
o 9.3 Asia – Market size and forecast 2022-2027
o Exhibit 71: Chart on Asia – Market size and forecast 2022-2027 ($ billion)
o Exhibit 72: Data Table on Asia – Market size and forecast 2022-2027 ($ billion)
o Exhibit 73: Chart on Asia – Year-over-year growth 2022-2027 (%)
o Exhibit 74: Data Table on Asia – Year-over-year growth 2022-2027 (%)
o 9.4 Europe – Market size and forecast 2022-2027
o Exhibit 75: Chart on Europe – Market size and forecast 2022-2027 ($ billion)
o Exhibit 76: Data Table on Europe – Market size and forecast 2022-2027 ($ billion)
o Exhibit 77: Chart on Europe – Year-over-year growth 2022-2027 (%)
o Exhibit 78: Data Table on Europe – Year-over-year growth 2022-2027 (%)
o 9.5 North America – Market size and forecast 2022-2027
o Exhibit 79: Chart on North America – Market size and forecast 2022-2027 ($ billion)
o Exhibit 80: Data Table on North America – Market size and forecast 2022-2027 ($ billion)
o Exhibit 81: Chart on North America – Year-over-year growth 2022-2027 (%)
o Exhibit 82: Data Table on North America – Year-over-year growth 2022-2027 (%)
o 9.6 Rest of World (ROW) – Market size and forecast 2022-2027
o Exhibit 83: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
o Exhibit 84: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
o Exhibit 85: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o Exhibit 86: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
o 9.7 US – Market size and forecast 2022-2027
o Exhibit 87: Chart on US – Market size and forecast 2022-2027 ($ billion)
o Exhibit 88: Data Table on US – Market size and forecast 2022-2027 ($ billion)
o Exhibit 89: Chart on US – Year-over-year growth 2022-2027 (%)
o Exhibit 90: Data Table on US – Year-over-year growth 2022-2027 (%)
o 9.8 Japan – Market size and forecast 2022-2027
o Exhibit 91: Chart on Japan – Market size and forecast 2022-2027 ($ billion)
o Exhibit 92: Data Table on Japan – Market size and forecast 2022-2027 ($ billion)
o Exhibit 93: Chart on Japan – Year-over-year growth 2022-2027 (%)
o Exhibit 94: Data Table on Japan – Year-over-year growth 2022-2027 (%)
o 9.9 China – Market size and forecast 2022-2027
o Exhibit 95: Chart on China – Market size and forecast 2022-2027 ($ billion)
o Exhibit 96: Data Table on China – Market size and forecast 2022-2027 ($ billion)
o Exhibit 97: Chart on China – Year-over-year growth 2022-2027 (%)
o Exhibit 98: Data Table on China – Year-over-year growth 2022-2027 (%)
o 9.10 UK – Market size and forecast 2022-2027
o Exhibit 99: Chart on UK – Market size and forecast 2022-2027 ($ billion)
o Exhibit 100: Data Table on UK – Market size and forecast 2022-2027 ($ billion)
o Exhibit 101: Chart on UK – Year-over-year growth 2022-2027 (%)
o Exhibit 102: Data Table on UK – Year-over-year growth 2022-2027 (%)
o 9.11 Germany – Market size and forecast 2022-2027
o Exhibit 103: Chart on Germany – Market size and forecast 2022-2027 ($ billion)
o Exhibit 104: Data Table on Germany – Market size and forecast 2022-2027 ($ billion)
o Exhibit 105: Chart on Germany – Year-over-year growth 2022-2027 (%)
o Exhibit 106: Data Table on Germany – Year-over-year growth 2022-2027 (%)
o 9.12 Market opportunity By Geographical Landscape
o Exhibit 107: Market opportunity By Geographical Landscape ($ billion)
o Exhibit 108: Data Tables on Market opportunity By Geographical Landscape ($ billion)
10 Drivers, Challenges, and Trends
o 10.1 Market drivers
o 10.2 Market challenges
o 10.3 Impact of drivers and challenges
o Exhibit 109: Impact of drivers and challenges in 2022 and 2027
o 10.4 Market trends
11 Vendor Landscape
o 11.1 Overview
o 11.2 Vendor landscape
o Exhibit 110: Overview on Criticality of inputs and Factors of differentiation
o 11.3 Landscape disruption
o Exhibit 111: Overview on factors of disruption
o 11.4 Industry risks
o Exhibit 112: Impact of key risks on business
12 Vendor Analysis
o 12.1 Vendors covered
o Exhibit 113: Vendors covered
o 12.2 Market positioning of vendors
o Exhibit 114: Matrix on vendor position and classification
o 12.3 Bausch Health Co. Inc.
o Exhibit 115: Bausch Health Co. Inc. – Overview
o Exhibit 116: Bausch Health Co. Inc. – Business segments
o Exhibit 117: Bausch Health Co. Inc. – Key news
o Exhibit 118: Bausch Health Co. Inc. – Key offerings
o Exhibit 119: Bausch Health Co. Inc. – Segment focus
o 12.4 Bayer AG
o Exhibit 120: Bayer AG – Overview
o Exhibit 121: Bayer AG – Business segments
o Exhibit 122: Bayer AG – Key news
o Exhibit 123: Bayer AG – Key offerings
o Exhibit 124: Bayer AG – Segment focus
o 12.5 Dr. Willmar Schwabe GmbH and Co. KG
o Exhibit 125: Dr. Willmar Schwabe GmbH and Co. KG – Overview
o Exhibit 126: Dr. Willmar Schwabe GmbH and Co. KG – Product / Service
o Exhibit 127: Dr. Willmar Schwabe GmbH and Co. KG – Key offerings
o 12.6 F. Hoffmann La Roche Ltd.
o Exhibit 128: F. Hoffmann La Roche Ltd. – Overview
o Exhibit 129: F. Hoffmann La Roche Ltd. – Business segments
o Exhibit 130: F. Hoffmann La Roche Ltd. – Key news
o Exhibit 131: F. Hoffmann La Roche Ltd. – Key offerings
o Exhibit 132: F. Hoffmann La Roche Ltd. – Segment focus
o 12.7 Hetero Labs Ltd.
o Exhibit 133: Hetero Labs Ltd. – Overview
o Exhibit 134: Hetero Labs Ltd. – Product / Service
o Exhibit 135: Hetero Labs Ltd. – Key offerings
o 12.8 Jaguar Health Inc.
o Exhibit 136: Jaguar Health Inc. – Overview
o Exhibit 137: Jaguar Health Inc. – Business segments
o Exhibit 138: Jaguar Health Inc. – Key offerings
o Exhibit 139: Jaguar Health Inc. – Segment focus
o 12.9 Jazz Pharmaceuticals Plc
o Exhibit 140: Jazz Pharmaceuticals Plc – Overview
o Exhibit 141: Jazz Pharmaceuticals Plc – Product / Service
o Exhibit 142: Jazz Pharmaceuticals Plc – Key news
o Exhibit 143: Jazz Pharmaceuticals Plc – Key offerings
o 12.10 Johnson and Johnson Services Inc.
o Exhibit 144: Johnson and Johnson Services Inc. – Overview
o Exhibit 145: Johnson and Johnson Services Inc. – Business segments
o Exhibit 146: Johnson and Johnson Services Inc. – Key news
o Exhibit 147: Johnson and Johnson Services Inc. – Key offerings
o Exhibit 148: Johnson and Johnson Services Inc. – Segment focus
o 12.11 Merck KGaA
o Exhibit 149: Merck KGaA – Overview
o Exhibit 150: Merck KGaA – Business segments
o Exhibit 151: Merck KGaA – Key news
o Exhibit 152: Merck KGaA – Key offerings
o Exhibit 153: Merck KGaA – Segment focus
o 12.12 Mitsubishi Chemical Group Corp.
o Exhibit 154: Mitsubishi Chemical Group Corp. – Overview
o Exhibit 155: Mitsubishi Chemical Group Corp. – Business segments
o Exhibit 156: Mitsubishi Chemical Group Corp. – Key offerings
o Exhibit 157: Mitsubishi Chemical Group Corp. – Segment focus
o 12.13 Novartis AG
o Exhibit 158: Novartis AG – Overview
o Exhibit 159: Novartis AG – Business segments
o Exhibit 160: Novartis AG – Key offerings
o Exhibit 161: Novartis AG – Segment focus
o 12.14 Pierre Fabre SA
o Exhibit 162: Pierre Fabre SA – Overview
o Exhibit 163: Pierre Fabre SA – Business segments
o Exhibit 164: Pierre Fabre SA – Key offerings
o Exhibit 165: Pierre Fabre SA – Segment focus
o 12.15 Protalix Biotherapeutics Inc.
o Exhibit 166: Protalix Biotherapeutics Inc. – Overview
o Exhibit 167: Protalix Biotherapeutics Inc. – Product / Service
o Exhibit 168: Protalix Biotherapeutics Inc. – Key offerings
o 12.16 Sanofi
o Exhibit 169: Sanofi – Overview
o Exhibit 170: Sanofi – Business segments
o Exhibit 171: Sanofi – Key news
o Exhibit 172: Sanofi – Key offerings
o Exhibit 173: Sanofi – Segment focus
o 12.17 Sun Pharmaceutical Industries Ltd.
o Exhibit 174: Sun Pharmaceutical Industries Ltd. – Overview
o Exhibit 175: Sun Pharmaceutical Industries Ltd. – Product / Service
o Exhibit 176: Sun Pharmaceutical Industries Ltd. – Key offerings
13 Appendix
o 13.1 Scope of the report
o 13.2 Inclusions and exclusions checklist
o Exhibit 177: Inclusions checklist
o Exhibit 178: Exclusions checklist
o 13.3 Currency conversion rates for US$
o Exhibit 179: Currency conversion rates for US$
o 13.4 Research methodology
o Exhibit 180: Research methodology
o Exhibit 181: Validation techniques employed for market sizing
o Exhibit 182: Information sources
o 13.5 List of abbreviations
o Exhibit 183: List of abbreviations

Exhibits:
Exhibits1: Executive Summary – Chart on Market Overview
Exhibits2: Executive Summary – Data Table on Market Overview
Exhibits3: Executive Summary – Chart on Global Market Characteristics
Exhibits4: Executive Summary – Chart on Market By Geographical Landscape
Exhibits5: Executive Summary – Chart on Market Segmentation by Product
Exhibits6: Executive Summary – Chart on Market Segmentation by Application
Exhibits7: Executive Summary – Chart on Incremental Growth
Exhibits8: Executive Summary – Data Table on Incremental Growth
Exhibits9: Executive Summary – Chart on Vendor Market Positioning
Exhibits10: Parent market
Exhibits11: Market Characteristics
Exhibits12: Offerings of vendors included in the market definition
Exhibits13: Market segments
Exhibits14: Chart on Global – Market size and forecast 2022-2027 ($ billion)
Exhibits15: Data Table on Global – Market size and forecast 2022-2027 ($ billion)
Exhibits16: Chart on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits17: Data Table on Global Market: Year-over-year growth 2022-2027 (%)
Exhibits18: Historic Market Size – Data Table on global botanical and plant-derived drugs market 2017 – 2021 ($ billion)
Exhibits19: Historic Market Size – Product Segment 2017 – 2021 ($ billion)
Exhibits20: Historic Market Size – Application Segment 2017 – 2021 ($ billion)
Exhibits21: Historic Market Size – Geography Segment 2017 – 2021 ($ billion)
Exhibits22: Historic Market Size – Country Segment 2017 – 2021 ($ billion)
Exhibits23: Five forces analysis – Comparison between 2022 and 2027
Exhibits24: Chart on Bargaining power of buyers – Impact of key factors 2022 and 2027
Exhibits25: Bargaining power of suppliers – Impact of key factors in 2022 and 2027
Exhibits26: Threat of new entrants – Impact of key factors in 2022 and 2027
Exhibits27: Threat of substitutes – Impact of key factors in 2022 and 2027
Exhibits28: Threat of rivalry – Impact of key factors in 2022 and 2027
Exhibits29: Chart on Market condition – Five forces 2022 and 2027
Exhibits30: Chart on Product – Market share 2022-2027 (%)
Exhibits31: Data Table on Product – Market share 2022-2027 (%)
Exhibits32: Chart on Comparison by Product
Exhibits33: Data Table on Comparison by Product
Exhibits34: Chart on Plant-derived drugs – Market size and forecast 2022-2027 ($ billion)
Exhibits35: Data Table on Plant-derived drugs – Market size and forecast 2022-2027 ($ billion)
Exhibits36: Chart on Plant-derived drugs – Year-over-year growth 2022-2027 (%)
Exhibits37: Data Table on Plant-derived drugs – Year-over-year growth 2022-2027 (%)
Exhibits38: Chart on Botanical drugs – Market size and forecast 2022-2027 ($ billion)
Exhibits39: Data Table on Botanical drugs – Market size and forecast 2022-2027 ($ billion)
Exhibits40: Chart on Botanical drugs – Year-over-year growth 2022-2027 (%)
Exhibits41: Data Table on Botanical drugs – Year-over-year growth 2022-2027 (%)
Exhibits42: Market opportunity by Product ($ billion)
Exhibits43: Data Table on Market opportunity by Product ($ billion)
Exhibits44: Chart on Application – Market share 2022-2027 (%)
Exhibits45: Data Table on Application – Market share 2022-2027 (%)
Exhibits46: Chart on Comparison by Application
Exhibits47: Data Table on Comparison by Application
Exhibits48: Chart on Infectious diseases – Market size and forecast 2022-2027 ($ billion)
Exhibits49: Data Table on Infectious diseases – Market size and forecast 2022-2027 ($ billion)
Exhibits50: Chart on Infectious diseases – Year-over-year growth 2022-2027 (%)
Exhibits51: Data Table on Infectious diseases – Year-over-year growth 2022-2027 (%)
Exhibits52: Chart on Central nervous system – Market size and forecast 2022-2027 ($ billion)
Exhibits53: Data Table on Central nervous system – Market size and forecast 2022-2027 ($ billion)
Exhibits54: Chart on Central nervous system – Year-over-year growth 2022-2027 (%)
Exhibits55: Data Table on Central nervous system – Year-over-year growth 2022-2027 (%)
Exhibits56: Chart on Cardiovascular diseases – Market size and forecast 2022-2027 ($ billion)
Exhibits57: Data Table on Cardiovascular diseases – Market size and forecast 2022-2027 ($ billion)
Exhibits58: Chart on Cardiovascular diseases – Year-over-year growth 2022-2027 (%)
Exhibits59: Data Table on Cardiovascular diseases – Year-over-year growth 2022-2027 (%)
Exhibits60: Chart on Respiratory diseases – Market size and forecast 2022-2027 ($ billion)
Exhibits61: Data Table on Respiratory diseases – Market size and forecast 2022-2027 ($ billion)
Exhibits62: Chart on Respiratory diseases – Year-over-year growth 2022-2027 (%)
Exhibits63: Data Table on Respiratory diseases – Year-over-year growth 2022-2027 (%)
Exhibits64: Market opportunity by Application ($ billion)
Exhibits65: Data Table on Market opportunity by Application ($ billion)
Exhibits66: Analysis of price sensitivity, lifecycle, customer purchase basket, adoption rates, and purchase criteria
Exhibits67: Chart on Market share By Geographical Landscape 2022-2027 (%)
Exhibits68: Data Table on Market share By Geographical Landscape 2022-2027 (%)
Exhibits69: Chart on Geographic comparison
Exhibits70: Data Table on Geographic comparison
Exhibits71: Chart on Asia – Market size and forecast 2022-2027 ($ billion)
Exhibits72: Data Table on Asia – Market size and forecast 2022-2027 ($ billion)
Exhibits73: Chart on Asia – Year-over-year growth 2022-2027 (%)
Exhibits74: Data Table on Asia – Year-over-year growth 2022-2027 (%)
Exhibits75: Chart on Europe – Market size and forecast 2022-2027 ($ billion)
Exhibits76: Data Table on Europe – Market size and forecast 2022-2027 ($ billion)
Exhibits77: Chart on Europe – Year-over-year growth 2022-2027 (%)
Exhibits78: Data Table on Europe – Year-over-year growth 2022-2027 (%)
Exhibits79: Chart on North America – Market size and forecast 2022-2027 ($ billion)
Exhibits80: Data Table on North America – Market size and forecast 2022-2027 ($ billion)
Exhibits81: Chart on North America – Year-over-year growth 2022-2027 (%)
Exhibits82: Data Table on North America – Year-over-year growth 2022-2027 (%)
Exhibits83: Chart on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
Exhibits84: Data Table on Rest of World (ROW) – Market size and forecast 2022-2027 ($ billion)
Exhibits85: Chart on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits86: Data Table on Rest of World (ROW) – Year-over-year growth 2022-2027 (%)
Exhibits87: Chart on US – Market size and forecast 2022-2027 ($ billion)
Exhibits88: Data Table on US – Market size and forecast 2022-2027 ($ billion)
Exhibits89: Chart on US – Year-over-year growth 2022-2027 (%)
Exhibits90: Data Table on US – Year-over-year growth 2022-2027 (%)
Exhibits91: Chart on Japan – Market size and forecast 2022-2027 ($ billion)
Exhibits92: Data Table on Japan – Market size and forecast 2022-2027 ($ billion)
Exhibits93: Chart on Japan – Year-over-year growth 2022-2027 (%)
Exhibits94: Data Table on Japan – Year-over-year growth 2022-2027 (%)
Exhibits95: Chart on China – Market size and forecast 2022-2027 ($ billion)
Exhibits96: Data Table on China – Market size and forecast 2022-2027 ($ billion)
Exhibits97: Chart on China – Year-over-year growth 2022-2027 (%)
Exhibits98: Data Table on China – Year-over-year growth 2022-2027 (%)
Exhibits99: Chart on UK – Market size and forecast 2022-2027 ($ billion)
Exhibits100: Data Table on UK – Market size and forecast 2022-2027 ($ billion)
Exhibits101: Chart on UK – Year-over-year growth 2022-2027 (%)
Exhibits102: Data Table on UK – Year-over-year growth 2022-2027 (%)
Exhibits103: Chart on Germany – Market size and forecast 2022-2027 ($ billion)
Exhibits104: Data Table on Germany – Market size and forecast 2022-2027 ($ billion)
Exhibits105: Chart on Germany – Year-over-year growth 2022-2027 (%)
Exhibits106: Data Table on Germany – Year-over-year growth 2022-2027 (%)
Exhibits107: Market opportunity By Geographical Landscape ($ billion)
Exhibits108: Data Tables on Market opportunity By Geographical Landscape ($ billion)
Exhibits109: Impact of drivers and challenges in 2022 and 2027
Exhibits110: Overview on Criticality of inputs and Factors of differentiation
Exhibits111: Overview on factors of disruption
Exhibits112: Impact of key risks on business
Exhibits113: Vendors covered
Exhibits114: Matrix on vendor position and classification
Exhibits115: Bausch Health Co. Inc. – Overview
Exhibits116: Bausch Health Co. Inc. – Business segments
Exhibits117: Bausch Health Co. Inc. – Key news
Exhibits118: Bausch Health Co. Inc. – Key offerings
Exhibits119: Bausch Health Co. Inc. – Segment focus
Exhibits120: Bayer AG – Overview
Exhibits121: Bayer AG – Business segments
Exhibits122: Bayer AG – Key news
Exhibits123: Bayer AG – Key offerings
Exhibits124: Bayer AG – Segment focus
Exhibits125: Dr. Willmar Schwabe GmbH and Co. KG – Overview
Exhibits126: Dr. Willmar Schwabe GmbH and Co. KG – Product / Service
Exhibits127: Dr. Willmar Schwabe GmbH and Co. KG – Key offerings
Exhibits128: F. Hoffmann La Roche Ltd. – Overview
Exhibits129: F. Hoffmann La Roche Ltd. – Business segments
Exhibits130: F. Hoffmann La Roche Ltd. – Key news
Exhibits131: F. Hoffmann La Roche Ltd. – Key offerings
Exhibits132: F. Hoffmann La Roche Ltd. – Segment focus
Exhibits133: Hetero Labs Ltd. – Overview
Exhibits134: Hetero Labs Ltd. – Product / Service
Exhibits135: Hetero Labs Ltd. – Key offerings
Exhibits136: Jaguar Health Inc. – Overview
Exhibits137: Jaguar Health Inc. – Business segments
Exhibits138: Jaguar Health Inc. – Key offerings
Exhibits139: Jaguar Health Inc. – Segment focus
Exhibits140: Jazz Pharmaceuticals Plc – Overview
Exhibits141: Jazz Pharmaceuticals Plc – Product / Service
Exhibits142: Jazz Pharmaceuticals Plc – Key news
Exhibits143: Jazz Pharmaceuticals Plc – Key offerings
Exhibits144: Johnson and Johnson Services Inc. – Overview
Exhibits145: Johnson and Johnson Services Inc. – Business segments
Exhibits146: Johnson and Johnson Services Inc. – Key news
Exhibits147: Johnson and Johnson Services Inc. – Key offerings
Exhibits148: Johnson and Johnson Services Inc. – Segment focus
Exhibits149: Merck KGaA – Overview
Exhibits150: Merck KGaA – Business segments
Exhibits151: Merck KGaA – Key news
Exhibits152: Merck KGaA – Key offerings
Exhibits153: Merck KGaA – Segment focus
Exhibits154: Mitsubishi Chemical Group Corp. – Overview
Exhibits155: Mitsubishi Chemical Group Corp. – Business segments
Exhibits156: Mitsubishi Chemical Group Corp. – Key offerings
Exhibits157: Mitsubishi Chemical Group Corp. – Segment focus
Exhibits158: Novartis AG – Overview
Exhibits159: Novartis AG – Business segments
Exhibits160: Novartis AG – Key offerings
Exhibits161: Novartis AG – Segment focus
Exhibits162: Pierre Fabre SA – Overview
Exhibits163: Pierre Fabre SA – Business segments
Exhibits164: Pierre Fabre SA – Key offerings
Exhibits165: Pierre Fabre SA – Segment focus
Exhibits166: Protalix Biotherapeutics Inc. – Overview
Exhibits167: Protalix Biotherapeutics Inc. – Product / Service
Exhibits168: Protalix Biotherapeutics Inc. – Key offerings
Exhibits169: Sanofi – Overview
Exhibits170: Sanofi – Business segments
Exhibits171: Sanofi – Key news
Exhibits172: Sanofi – Key offerings
Exhibits173: Sanofi – Segment focus
Exhibits174: Sun Pharmaceutical Industries Ltd. – Overview
Exhibits175: Sun Pharmaceutical Industries Ltd. – Product / Service
Exhibits176: Sun Pharmaceutical Industries Ltd. – Key offerings
Exhibits177: Inclusions checklist
Exhibits178: Exclusions checklist
Exhibits179: Currency conversion rates for US$
Exhibits180: Research methodology
Exhibits181: Validation techniques employed for market sizing
Exhibits182: Information sources
Exhibits183: List of abbreviations

※본 조사보고서 [글로벌 식물성 및 식물 유래 의약품 시장 2023-2027 : 식물약, 식물성 의약품] (코드 : IRTNTR45751-23) 판매에 관한 면책사항을 반드시 확인하세요.
※본 조사보고서 [글로벌 식물성 및 식물 유래 의약품 시장 2023-2027 : 식물약, 식물성 의약품] 에 대해서 E메일 문의는 여기를 클릭하세요.
※당 사이트에 없는 보고서도 취급 가능한 경우가 많으니 문의 주세요!